(Louis) Interpreter of Maladies (Large Print)
by American Printing House for the Blind
Last verified June 15, 2026 · classified June 15, 2026
What it is
Summary
AI-generated from vendor-published content · June 15, 2026
This is a large-print edition of Jhumpa Lahiri's short story collection 'Interpreter of Maladies,' produced by the American Printing House for the Blind (APH) for readers with low vision or blindness. Large-print books from APH use standardized high-contrast formatting with significantly enlarged type to allow people with reduced visual acuity to read standard literary texts without assistive technology like magnifiers or screen readers. This is a complete, ready-to-use physical book — open it and read. APH large-print titles are Federal Quota eligible, meaning they can be funded through the educational quota system for qualifying students who are blind or visually impaired. At roughly 4 lbs, this is a substantial physical volume; large-print editions are necessarily larger and heavier than standard print.
Quick Facts Catalog facts · auto-generated
- AT Act lending
- Out of pocket
- School district
What Setup Looks Like
- Out of the box
Open the book and read — no setup, charging, or pairing required.
Getting it
Try Before You Buy
Devices like this are often available to borrow through your state's AT Act program — typically free or low-cost — so you can try it before buying or pursuing funding.
Where to Get It
Some links may be affiliate links — WhatCanHelp may earn a small commission from purchases at no extra cost to you. More on affiliates →
Wondering how equipment like this gets paid for? See the official funding programs in your state.
Compare & explore
Sources & fine print
Vendor facts (name, price, platforms, vendor link) sourced from American Printing House for the Blind — view on vendor site; last verified June 15, 2026.
Classification & description AI-generated from vendor-published content on June 15, 2026 · confidence: high. Vendor specs may lag; verify before relying on details in a clinical or funding artifact.